Health
SRI has been a leader for decades in the development of tools, technologies, and therapeutics that have saved and improved countless lives around the world. Our Biosciences division works with government and commercial clients to seamlessly integrate basic and translational research, drug discovery, and nonclinical and clinical development.
-
Tyson McDonald: How radiation impacts human biology in space and on Earth
A switch from studying medical physics to radiation biology charted the course for fascinating research.
-
SRI’s Genome Explorer: Enhanced genome browser delivers better user experience
Navigating genomes just became easier with dynamically responsive zoom and high-density display.
-
A new malaria treatment aims to provide protection from the disease
The injectable formulation is affordable and easily administered.
-
SRI sleep expert Fiona Baker discusses menopausal insomnia
Researchers study how menopause can affect sleep and women’s physical and mental health.
-
SRI researchers use AI to study deadly viruses
Machine learning algorithms identify how hemorrhagic fever viruses hijack human cells.
-
SRI demonstrates the impact of “small AI” for experts
DASL combines machine learning and human expertise to provide insights for a variety of applications.
-
SRI earns FDA Orphan Drug Designation for pancreatic cancer
The designation accelerates clinical development of SRI’s TALL® immunotherapy and brings more affordable therapies to market faster.
-
SRI works with N4 Pharma to target and treat cells in the human body that had been unreachable
Paving the way for targeted treatments, the collaboration aims to help realize the full potential of precision healthcare.
-
Carol Green: Helping new drugs make the leap from possible to practical
Leading the effort to make sure effective therapies progress to human trials.
-
Gita Shankar: Formulating drugs for success
SRI’s director of pharmaceutical sciences works to bring new drugs safely to market while serving as a role model for women in STEM.
-
Exploring the American Dream: A Lively Discussion on Innovation and Progress
Watch the video: A conversation with SRI’s David Parekh and David Leonhardt of the New York Times.
-
Laura Atleski Magda: Making clinical research accessible for all
The director of SRI’s Clinical Trials Unit explores how increased access to clinical research can improve public health.